Servier’s Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions
Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and the Prix Galien Bridges Awards for Best Product…
Geleximco Group and China intelligent chassis solution provider Leekr Technology signed a MoU to deepen industrial collaboration
SHANGHAI, Dec. 8, 2025 /PRNewswire/ — Geleximco Group and Leekr Technology, a leading Chinese provider of intelligent chassis system solutions,…
Allison Worldwide Expands Global Leadership with New Europe CEO
Former Hotwire UK CEO and Edelman MD Jeremy Lucas to turbocharge Allison’s European capabilities LONDON, Dec. 8, 2025 /PRNewswire/ —…
Through Faith and Practice, Mary Bass Gray Helps Readers Reflect on God’s Character and Pursue His Perfection
“Practice Makes Perfect” offers a roadmap to spiritual maturity in an imperfect world WEST MONROE, La., Dec. 8, 2025 /PRNewswire/…
NUNM Finalizes Campus Purchase, Strengthening Healthcare Education and Community Services in Portland
PORTLAND, Ore., Dec. 8, 2025 /PRNewswire/ — The National University of Natural Medicine (NUNM) has finalized the purchase of the…
Pepperstone Expands UAE Presence with SCA Category 5 Licence and New Dubai Office
DUBAI, UAE, Dec. 8, 2025 /PRNewswire/ — Pepperstone, a leading global online broker, has expanded its footprint in the UAE…
Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight
– ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau…
iScreen Widget Adds Customizable Snow Globe Widget in Christmas-Themed Update for iOS 26 and Android
Holiday update adds interactive widgets, themed layouts, and seasonal wallpapers for device customization. LOS ANGELES, Dec. 8, 2025 /PRNewswire/ — iScreen,…
Acer Reports Revenues for November at NT$24.60 Billion with Growth of 15.9% Month-on-month and 8.1% Year-on-year
TAIPEI, Dec. 8, 2025 /PRNewswire/ — Acer Inc. (TWSE: 2353) announced its consolidated revenues for November at NT$24.60 billion, up…
Sennics Unveils Major Breakthroughs in New Eco-Friendly Antioxidant SA6000
SHANGHAI, Dec. 8, 2025 /PRNewswire/ — On December 8, 2025, to commemorate the second anniversary of the Seminar on Future…
PENETRON ADMIX Protects Australian Luxury Residences from Maritime Climate
ORLANDO, Fla., Dec. 8, 2025 /PRNewswire-PRWeb/ — Residents of the Heritage North Wollongong luxury apartments in North Wollongong (NSW), Australia,…
Personar Appoints Sports Industry Veteran Tony Page as Managing Director for Global Professional Sports
Leading AI sports technology company strengthens executive team with former Sony Hawk-Eye Innovations Managing Director as it scales globally LONDON,…
EQT agrees to sale of shares in Galderma Group AG to L’Oréal S.A.
C. 24 million shares to be sold STOCKHOLM, Dec. 8, 2025 /PRNewswire/ — Further to previous announcements, an affiliate of…
GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’
– First anthrax vaccine developed using recombinant DNA technology– Annual production capacity of up to 10 million doses at GC…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
↑